JPH02306991A - Cyclic acetal derivative of indophenyl-alpha-glycoside, its production and utilization thereof as reagent for measuring alpha-amylase activity - Google Patents
Cyclic acetal derivative of indophenyl-alpha-glycoside, its production and utilization thereof as reagent for measuring alpha-amylase activityInfo
- Publication number
- JPH02306991A JPH02306991A JP12809089A JP12809089A JPH02306991A JP H02306991 A JPH02306991 A JP H02306991A JP 12809089 A JP12809089 A JP 12809089A JP 12809089 A JP12809089 A JP 12809089A JP H02306991 A JPH02306991 A JP H02306991A
- Authority
- JP
- Japan
- Prior art keywords
- group
- cyclic acetal
- indophenyl
- alpha
- glycoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 Cyclic acetal Chemical class 0.000 title claims abstract description 23
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 102000004139 alpha-Amylases Human genes 0.000 title abstract description 17
- 108090000637 alpha-Amylases Proteins 0.000 title abstract description 17
- 229940024171 alpha-amylase Drugs 0.000 title abstract description 17
- 230000000694 effects Effects 0.000 title abstract description 17
- 239000003153 chemical reaction reagent Substances 0.000 title abstract description 4
- 238000004519 manufacturing process Methods 0.000 title description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 125000003118 aryl group Chemical group 0.000 claims abstract description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims abstract description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims abstract description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 3
- 125000004962 sulfoxyl group Chemical group 0.000 claims abstract description 3
- 125000005031 thiocyano group Chemical group S(C#N)* 0.000 claims abstract description 3
- 125000002252 acyl group Chemical group 0.000 claims abstract 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims abstract 2
- 239000000758 substrate Substances 0.000 claims description 14
- 238000005259 measurement Methods 0.000 claims description 11
- 229930182470 glycoside Natural products 0.000 claims description 10
- 150000002338 glycosides Chemical class 0.000 claims description 10
- 239000004382 Amylase Substances 0.000 claims description 9
- 102000013142 Amylases Human genes 0.000 claims description 9
- 108010065511 Amylases Proteins 0.000 claims description 9
- 235000019418 amylase Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 102000004366 Glucosidases Human genes 0.000 claims description 6
- 108010056771 Glucosidases Proteins 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 claims description 2
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N isonitrile group Chemical group N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 24
- 150000004059 quinone derivatives Chemical class 0.000 abstract description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- IZYGWQAPRLNOIX-UHFFFAOYSA-N isocyanoimino(sulfanylidene)methane Chemical compound S=C=N[N+]#[C-] IZYGWQAPRLNOIX-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 13
- 108010028144 alpha-Glucosidases Proteins 0.000 description 12
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 102000006995 beta-Glucosidase Human genes 0.000 description 8
- 108010047754 beta-Glucosidase Proteins 0.000 description 8
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- PCKPVGOLPKLUHR-UHFFFAOYSA-N indoxyl Chemical group C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 description 4
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012024 dehydrating agents Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 1
- YXGBAQKCCMQLGH-MYPSSPKESA-N (2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5- Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](OC=5C=CC(=CC=5)[N+]([O-])=O)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O YXGBAQKCCMQLGH-MYPSSPKESA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- KNPAQJBQOIAPBP-UHFFFAOYSA-N 2,5-dibromocyclohexa-2,5-diene-1,4-dione Chemical compound BrC1=CC(=O)C(Br)=CC1=O KNPAQJBQOIAPBP-UHFFFAOYSA-N 0.000 description 1
- JCARTGJGWCGSSU-UHFFFAOYSA-N 2,6-dichlorobenzoquinone Chemical compound ClC1=CC(=O)C=C(Cl)C1=O JCARTGJGWCGSSU-UHFFFAOYSA-N 0.000 description 1
- WOGWYSWDBYCVDY-UHFFFAOYSA-N 2-chlorocyclohexa-2,5-diene-1,4-dione Chemical compound ClC1=CC(=O)C=CC1=O WOGWYSWDBYCVDY-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 229910003074 TiCl4 Inorganic materials 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- SXUXONJXVIQGLC-UHFFFAOYSA-N oxathiirane 2,2-dioxide Chemical compound O=S1(=O)CO1 SXUXONJXVIQGLC-UHFFFAOYSA-N 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 150000002989 phenols Chemical group 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、多糖加水分解酵素、例えばアミラーゼの活性
を測定するのに有用なインドフェニル配糖体の環状アセ
タール誘導体およびその製法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a cyclic acetal derivative of indophenyl glycoside useful for measuring the activity of a polysaccharide hydrolase, such as amylase, and a method for producing the same.
膵臓や尿などの体液に含有されるα−アミラーゼの活性
を測定することにより、各種疾患の診断が行われている
。アミラーゼの活性測定法にはオリゴ糖の還元末端位に
フェノール誘導体が結合した、例えばp−ニトロフェニ
ルマルトペンタオシド(特公昭57−53079号公報
)、P−ニトロフェニルマルトへキサオシド(特公昭5
7−53079号公報)、p−ニトロフェニルマルトへ
ブタオシド(特開昭54−51892号公tl) 、p
−ニトロフェニルマルトへブタオシド(特開昭54−5
1892号公報)、2,4−ジクロ−ロフェニルマルト
ベンタオシド(特開昭56−35998号公報)などが
基質として利用される。Various diseases are diagnosed by measuring the activity of α-amylase contained in body fluids such as pancreas and urine. The amylase activity measurement method uses a method in which a phenol derivative is bound to the reducing end of an oligosaccharide, such as p-nitrophenylmaltopentaoside (Japanese Patent Publication No. 57-53079), p-nitrophenylmaltohexaoside (Japanese Patent Publication No. 57-53079),
7-53079), p-nitrophenylmaltohebutaoside (Japanese Unexamined Patent Publication No. 54-51892), p
-Nitrophenyl maltohebutaoside (JP-A-54-5
1892), 2,4-dichlorophenylmaltobentaoside (Japanese Unexamined Patent Publication No. 56-35998), and the like are used as substrates.
これらの基質は体液中のアミラーゼにより加水分解され
、生成したフラグメントがさらに予め含有しであるα又
はβ−グルコシダーゼによる加水分解を受けて例えばp
−二トロフェノールが′1JiL離して来る。このp−
ニトロフェノールを光学的に測定することにより、α−
アミラーゼ活性が容易に測定されうる。しかしこのよう
な基質を用いてα−アミラーゼ活性を測定する場合に光
吸収の測定は410nm付近のかなり短い波長で行う必
要があり、試料液例えば血清中に、ビリルビン等の短波
長に吸収を有する物質が存在すると、その妨害を受は易
い。These substrates are hydrolyzed by amylase in body fluids, and the resulting fragments are further hydrolyzed by α- or β-glucosidases, e.g.
-Ditrophenol comes at a distance of '1JiL. This p-
By optically measuring nitrophenol, α-
Amylase activity can be easily measured. However, when measuring α-amylase activity using such a substrate, it is necessary to measure light absorption at a fairly short wavelength around 410 nm. When a substance is present, it is easily susceptible to interference.
一方、このような問題のない方法としてインドキシルマ
ルトデキストリンを用いる方法が知られている(特開昭
56−103199号公報)。On the other hand, a method using indoxyl maltodextrin is known as a method free from such problems (Japanese Unexamined Patent Publication No. 103199/1983).
しかしながら、インドキシルマルトデキストリンは製造
が難しいこと、酸化剤によるインジコ色素の生成が遅い
点で優れた基質とは言い難い。また、予め含有しである
α又はβ−グルコシダーゼが僅かではあるが基質に作用
するため、ブランク値が上昇する欠点がある。このよう
な欠点を解消するため、マルトオリゴ塘の非還元性末端
のグルコースの4位又は6位のヒドロキシル基が修飾さ
れたタイプの基質を用いる方法が提案されている(例え
ば、特開昭60−237998号公報、特開昭61−6
3299号公報、特開昭63−17895号公報、特開
昭63−17895号公報、特開昭63−7797号公
報に開示されている。)、シかしながら、これらの基質
を用いた場合にも吸収波長のピークが410nm付近に
あるため血清の光吸収が大きく測定誤差が大きくなると
いう問題があった。However, indoxyl maltodextrin cannot be said to be an excellent substrate because it is difficult to produce and the production of indico dyes by oxidizing agents is slow. Furthermore, since the pre-contained α or β-glucosidase acts on the substrate, albeit slightly, there is a drawback that the blank value increases. In order to overcome these drawbacks, a method has been proposed that uses a type of substrate in which the hydroxyl group at the 4- or 6-position of the glucose at the non-reducing end of the malto-oligo is modified (for example, Japanese Patent Application Laid-open No. 1986-60-1). Publication No. 237998, JP-A-61-6
It is disclosed in JP-A No. 3299, JP-A-63-17895, JP-A-63-17895, and JP-A-63-7797. ), However, even when these substrates are used, there is a problem that the peak of the absorption wavelength is around 410 nm, so the light absorption of serum is large and the measurement error becomes large.
本発明の目的は、α−アミラーゼにおいて血中の色素、
例えばビリルビンやヘモグロビンによる妨害や、予め含
有しであるα又はβ−グルコシダーゼによる基質の分解
を受けにくく、簡単な操作で、しかも検出感度の高い測
定を可能にする手段を提供することにある。The purpose of the present invention is to reduce pigments in blood in α-amylase,
For example, it is an object of the present invention to provide a means that is resistant to interference by bilirubin and hemoglobin and substrate decomposition by pre-contained α- or β-glucosidase, and that enables measurement with simple operation and high detection sensitivity.
本発明のα−アミラーゼの活性測定用゛試薬として適す
るインドフェニル配糖体の環状アセタール誘導体は非還
元性末端のグルコースの4位と6位がアセタール誘導体
で修飾され、還元性末端がインドフェニル誘導体で修飾
された化合物(1)で〔1〕
(式中、X、ないしX、は水素原子、ハロゲン原子、ニ
トロ基、シアノ基、アジド基、アシル基、スルホン酸基
、ニトロソ基、スルホニル基、スルホキシル基、チオシ
アノ基、イソチオシアノ基、イソニトリル基、イミノ基
、アゾ基、ジアゾ基、アルキル基、アリル基又はアリー
ル基を意味し、X3とX4及び/又はX、とX6は連結
して縮合芳香環を形成してもよい、R1又はR2は同一
または異なって水素原子、低級アルキル基またはフェニ
ル基を意味し低級アルキル基としてはメチル、エチル、
プロピル、イソプロピル、ブチル等を又はR8とR2が
共同してシクロヘキサン環、シクロペンクン環を形成し
てもよい。)で表されるインドフェニル配糖体である。The cyclic acetal derivative of indophenyl glycoside suitable as a reagent for measuring the activity of α-amylase of the present invention has the non-reducing terminal glucose at the 4- and 6-positions modified with an acetal derivative, and the reducing terminal modified with an indophenyl derivative. Compound (1) modified with [1] (wherein, It means a sulfoxyl group, thiocyano group, isothiocyano group, isonitrile group, imino group, azo group, diazo group, alkyl group, allyl group or aryl group, and X3 and X4 and/or X and X6 are connected to form a fused aromatic ring. R1 or R2 may be the same or different and represent a hydrogen atom, a lower alkyl group or a phenyl group, and examples of the lower alkyl group include methyl, ethyl,
Propyl, isopropyl, butyl, etc. or R8 and R2 may jointly form a cyclohexane ring or a cyclopenkune ring. ) is an indophenyl glycoside represented by
又nが3.4または5であることが特に好ましい。Further, it is particularly preferable that n is 3.4 or 5.
R7、Rtの低級アルキル基はメチル基、エチル基、プ
ロピル基、イソプロピル基、ブチル基等であり、nは3
.4又は5であることが特に好ましい。The lower alkyl group of R7 and Rt is a methyl group, ethyl group, propyl group, isopropyl group, butyl group, etc., and n is 3
.. 4 or 5 is particularly preferred.
次にインドフェニル配糖体の環状アセタール誘導体とし
ては例えば下記の化合物が挙げられる。Examples of cyclic acetal derivatives of indophenyl glycosides include the following compounds.
ただし以下の式でQは、 を表す(nは3又は5を表す)。However, in the following formula, Q is (n represents 3 or 5).
式iのインドフェニル配糖体の環状アセタール誘導体は
次式
する。)で表わされる4−アミノフェニル−配ti体の
環状アセタール誘導体に、次式
2式%
(式中X、ないしXhは前記の意味を有する。)で表わ
されるキノン誘導体を作用させることにより製造するこ
とができる。The cyclic acetal derivative of indophenyl glycoside of formula i is represented by the following formula. ) is produced by reacting a quinone derivative represented by the following formula 2 (wherein X and Xh have the above-mentioned meanings) with a cyclic acetal derivative of 4-aminophenyl-ligated body represented by be able to.
化合物■は例えば公知の方法(特開昭61−63299
号公報)で4−二トロフェニルーα−マルトペンタオシ
ドの非還元性末端4及び6位の水酸基をベンジリデンで
保護し、常法に従って、例えばラネーニッケル又はパラ
ジウム−カーボンを触媒に用い接触還元によってニトロ
基をアミン基に変換させることにより■を合成できる(
Can、J、Chem、38巻363頁1960年)。For example, compound
The non-reducing terminal hydroxyl groups at the 4 and 6 positions of 4-nitrophenyl-α-maltopentaoside are protected with benzylidene, and the nitro group is removed by catalytic reduction using Raney nickel or palladium-carbon as a catalyst according to a conventional method. ■ can be synthesized by converting into an amine group (
Can, J. Chem, vol. 38, p. 363, 1960).
化合物Hの例としては4−アミノフェニル−α−マルト
ペンタオース、4−アミノフェニル−2−クロロ−β−
マルトヘプタオース、4−アミノ−2,6−ジフルオロ
−β−マルトヘキサオース、4−アミノ−2−ブロモフ
ェニル−β−ヘプタオース等の環状アセタール誘導体が
挙げられ、更に具体的には頁8の(1)〜(6)に示し
た化合物が挙げられる。Examples of compound H include 4-aminophenyl-α-maltopentaose, 4-aminophenyl-2-chloro-β-
Examples include cyclic acetal derivatives such as maltoheptaose, 4-amino-2,6-difluoro-β-maltohexaose, and 4-amino-2-bromophenyl-β-heptaose, and more specifically, on page 8 ( Examples include the compounds shown in 1) to (6).
化合物■としては例えばP−キノン、2−クロロ−p−
キノン、2,6−ジクロロ−p−キノン、2.5−ジブ
ロモ−p−キノン、2.3,5.6−テトラクロロ−p
−キノン(クロラニル)、1.4−ナフトキノン、アン
スラキノン等が挙げられる。Examples of compound ① include P-quinone, 2-chloro-p-
Quinone, 2,6-dichloro-p-quinone, 2,5-dibromo-p-quinone, 2.3,5,6-tetrachloro-p
-quinone (chloranil), 1,4-naphthoquinone, anthraquinone and the like.
目的物質である化合物■を製造するに際しては、化合物
■を無水条件下で、中性有機溶媒に溶解し、中性脱水剤
を共存させ、触媒量の強酸を加えたのち、化合物■を作
用させることが好ましい。To produce compound ■, which is the target substance, compound ■ is dissolved in a neutral organic solvent under anhydrous conditions, a neutral dehydrating agent is coexisted, a catalytic amount of strong acid is added, and compound ■ is allowed to act. It is preferable.
化合物■の使用量は、化合物■の10〜50倍モル当量
、好ましくは15〜25倍モル当量である。The amount of Compound (1) to be used is 10 to 50 times the molar equivalent, preferably 15 to 25 times the molar equivalent of Compound (2).
中性有機溶媒としては、エーテル類例えばジエチルエー
テル、THF、ジオキサン等、炭化水素’M、例えばノ
ルマルヘキサン、ベンゼン、トルエン等、ハロゲン化炭
化水素類例えばジクロロメタン、クロロホルム、ジクロ
ロエタン、四塩化炭素等、ジメチルホルムアミド(DM
F)、ジメチルアセトアミド(DMA)、ヘキサホスホ
ラミド(HMPA) 、ジメチルスルホキシド(D M
S O)などが挙げられ、これらを組み合わせて用い
てもよい。Examples of neutral organic solvents include ethers such as diethyl ether, THF, dioxane, etc., hydrocarbons such as n-hexane, benzene, toluene, etc., halogenated hydrocarbons such as dichloromethane, chloroform, dichloroethane, carbon tetrachloride, etc., dimethyl Formamide (DM
F), dimethylacetamide (DMA), hexaphosphoramide (HMPA), dimethyl sulfoxide (DM
SO), etc., and these may be used in combination.
溶媒の量は、化合物■の重量の10〜100倍程度、好
ましくは40〜60倍である。The amount of the solvent is about 10 to 100 times, preferably 40 to 60 times, the weight of compound (1).
中性脱水剤としてはモレキュラシーブ、AhOr、Si
ng、無水Na、SOa、無水MgSO4等が挙げられ
、これらを組み合わせて用いてもよい。その量は、化合
物■の重量の0.5〜5倍、好ましくは0.8〜1.5
倍である。強酸としてはトリフルオロ酢酸、トリクロロ
酢酸、P−)ルエンスルホン酸、メタノスルホン酸、発
煙硫酸、AlCl3、BFff/Et、0、TiCl4
、FeClff等が挙げられ、これらを組み合わせて用
いてもよい。その量は化合物■の0.01〜0.1倍モ
ル当量好ましくは0.02〜0.04倍モル当量である
。As a neutral dehydrating agent, molecular sieve, AhOr, Si
ng, anhydrous Na, SOa, anhydrous MgSO4, etc., and these may be used in combination. The amount is 0.5 to 5 times the weight of compound (1), preferably 0.8 to 1.5 times the weight of compound (2).
It's double. Strong acids include trifluoroacetic acid, trichloroacetic acid, P-)luenesulfonic acid, methanosulfonic acid, fuming sulfuric acid, AlCl3, BFff/Et, 0, TiCl4
, FeClff, etc., and these may be used in combination. The amount thereof is 0.01 to 0.1 times the molar equivalent, preferably 0.02 to 0.04 times the molar equivalent of Compound (1).
反応温度及び反応時間は、化合物■、化合物■、溶媒及
び強酸の種類によって異なるが、通常反応温度は15〜
25゛Cであり、0.5〜4時間反応を継続して行うこ
とにより反応は終了する。The reaction temperature and reaction time vary depending on the type of compound ①, compound ②, solvent, and strong acid, but the reaction temperature is usually 15 to 15 minutes.
The reaction temperature is 25°C, and the reaction is completed by continuing the reaction for 0.5 to 4 hours.
反応終了後は反応液にアルカリを加えて中和し、水を加
えて化合物Iを水層に移行させる。中性有機溶媒層を分
離することによりそのなかに含まれている未反応のキノ
ン類を除く0分離した水層にアルコールを加えて化合物
を沈澱させ再結晶により精製することができる。さらに
ゲルクロマトグラフィー、吸着クロマトグラフィーなど
を利用することにより単一化合物として分離することが
できる。After the reaction is completed, an alkali is added to the reaction solution to neutralize it, and water is added to transfer Compound I to the aqueous layer. By separating the neutral organic solvent layer, unreacted quinones contained therein are removed. Alcohol is added to the separated aqueous layer to precipitate the compound, and the compound can be purified by recrystallization. Furthermore, it can be separated as a single compound by using gel chromatography, adsorption chromatography, etc.
本発明の化合物■はα−アミラーゼの検出及び定量測定
のための基質として有用である。Compound (1) of the present invention is useful as a substrate for the detection and quantitative measurement of α-amylase.
測定方法としては、この化合物1及びα又はβ−グルコ
シダーゼを含む水溶液を作成する。この水溶液には更に
pH$i街剤、グルコシダーゼの活性化剤、安定剤等を
含むことができる。グルコシダーゼは別の溶液としても
よいが、化合物■と同じ溶液にするのが測定操作上簡便
である。化合物1とグルコシダーゼを含む溶液に試料液
を加えて一定条件下で加温して酵素反応させる。その後
、酵素反応によって生成したインドフェノール化合物の
特性吸収波長における吸光度の変化を測定し、検M線を
利用してα−アミラーゼを定量することができる。As a measurement method, an aqueous solution containing this compound 1 and α- or β-glucosidase is prepared. This aqueous solution may further contain a pH-adjusting agent, a glucosidase activator, a stabilizer, and the like. Although glucosidase may be used in a separate solution, it is convenient for the measurement procedure to use the same solution as compound ①. A sample solution is added to a solution containing Compound 1 and glucosidase, and heated under certain conditions to cause an enzyme reaction. Thereafter, the change in absorbance at the characteristic absorption wavelength of the indophenol compound produced by the enzymatic reaction is measured, and α-amylase can be quantified using the M line.
(作用〕
本発明のインドフェニル配糖体の環状アセタール誘導体
はグルコース鎖部分とインドフェニル部分からなってお
り、まずα−アミラーゼによってグルコース鎖部分が切
断されてグルコース1又は2分子が残ったインドフェニ
ル化合物が生成する。(Action) The cyclic acetal derivative of indophenyl glycoside of the present invention consists of a glucose chain part and an indophenyl part, and the glucose chain part is first cleaved by α-amylase, and one or two molecules of glucose remain in the indophenyl part. Compounds are produced.
次に、α又はβ−グルコシダーゼが作用して残ったグル
コース分子を切り離し、インドフェノール化合物を遊離
させる。その結果、フェニル基の水酸基が解離して吸収
波長が変わる。その吸光度を測定することによってα−
アミラーゼを定量する。Next, alpha or beta-glucosidase acts to cleave off the remaining glucose molecules, liberating the indophenol compound. As a result, the hydroxyl group of the phenyl group dissociates and the absorption wavelength changes. By measuring its absorbance, α−
Quantify amylase.
本発明の化合物は非還元性末端のグルコースの4位と6
位がアセタール誘導体で修飾され還元性末端もインドフ
ェニル基が結合されているためグルコース鎖部分がα又
はβ−グルコシダーゼによって全く切断されない。The compounds of the present invention are present at the non-reducing terminal glucose positions 4 and 6.
Since the position is modified with an acetal derivative and the reducing end is also bonded with an indophenyl group, the glucose chain portion is not cleaved by α- or β-glucosidase at all.
イソプロピリデン−フェノールインド−フェニル−α−
ペンタオサイドの製造とこれを用いたα−アミラーゼの
測定
(1)イソプロピリデン−4−二トロフェニルーα−ペ
ンタオサイド(特開昭61−63299号公報記載の方
法を参考にして合成した。)5.OOgをメタノ−ル2
00dに溶解し、5%パラジウムカーボン1.0gを加
え、常圧下に水素ガスを導入しながら24時間撹拌した
0次いで、パラジウム−カーボンを濾別し、溶媒留去し
、イソプロパツールから再結晶すると、イソプロピリデ
ン−4−アミノフェニル−α−ペンタオサイドが285
g得られた。Isopropylidene-phenolindo-phenyl-α-
Production of pentaoside and measurement of α-amylase using the same (1) Isopropylidene-4-nitrophenyl-α-pentaoside (synthesized with reference to the method described in JP-A-61-63299)5. OOg to methanol 2
00d, 1.0 g of 5% palladium on carbon was added, and the mixture was stirred for 24 hours under normal pressure while introducing hydrogen gas.Next, palladium-carbon was filtered off, the solvent was distilled off, and recrystallized from isopropanol. Then, isopropylidene-4-aminophenyl-α-pentaoside is 285
g was obtained.
融点(’C);192〜195(分解)(2)p−ベン
ゾキノン18.0 gを1,4−ジオキサン100Id
に溶解し、さらにトリフルオロ酢酸0.5−及びモレキ
ュラシープ(4A)15gを加え、混和しておいた。こ
れに上記(1)で得たイソプロピリデン−4−アミノフ
ェニル−α−ペンタオサイド2、OOgを加え、室温下
30分間撹拌した。次に、ナトリウムメトキシドで反応
液を中和した。水20〇−を加えクロロホルムで過剰の
ベンゾキノンを除いた。水層を凍結乾燥し黄色物質を得
た。バイオゲル(P−2)で精製し、溶出した区分をイ
ンプロパツールから再結晶すると、イソプロピリデン−
フェノールインド−フェニル−α−ペンタオサイド0.
95 gが得られた。Melting point ('C); 192-195 (decomposition) (2) 18.0 g of p-benzoquinone was dissolved in 100 Id of 1,4-dioxane.
Further, 0.5 g of trifluoroacetic acid and 15 g of molecular sheep (4A) were added and mixed. To this was added OOg of isopropylidene-4-aminophenyl-α-pentaoside 2 obtained in (1) above, and the mixture was stirred at room temperature for 30 minutes. Next, the reaction solution was neutralized with sodium methoxide. 200ml of water was added and excess benzoquinone was removed with chloroform. The aqueous layer was freeze-dried to obtain a yellow substance. Purification with Biogel (P-2) and recrystallization of the eluted fraction from Improper Tool yields isopropylidene-
Phenolindo-phenyl-α-pentaoside 0.
95 g was obtained.
融点(’C);181〜183
紫外部・可視部吸収スペクトル;
スwax (nrm)=468.265赤外線吸収ス
ペクトル(CII+−1):1640.1620.14
91.1253.1082.1044.997.877
(3)次にアミラーゼ測定に際して問題となるα又はβ
−グルコシダーゼによる影ツの有無を調べた。Melting point ('C); 181-183 Ultraviolet/visible absorption spectrum; Swax (nrm) = 468.265 Infrared absorption spectrum (CII+-1): 1640.1620.14
91.1253.1082.1044.997.877 (3) Next, α or β, which is a problem when measuring amylase.
-The presence or absence of shadows caused by glucosidase was investigated.
フェノールインド−フェニル−α−ペンタオサイドとイ
ソプロピリデン−フェノールインド−フェニル−α−ペ
ンタオサイドをpl+6.7の50mMグツド緩衝液に
それぞれ4■/−になるように溶解し、2つの基質溶液
(A)、CB)を調製した。一方上記と同一の緩衝液に
α−グルコシダーゼが1500/ml!、β−グルコシ
ダーゼが200/dになる様に添加溶解して酵素溶液1
種を調製した。Phenolindo-phenyl-α-pentaoside and isopropylidene-phenolindo-phenyl-α-pentaoside were dissolved in 50mM Gud buffer at pl+6.7 to a concentration of 4/- each, and the two substrate solutions (A), CB) was prepared. On the other hand, the same buffer as above contains α-glucosidase at 1500/ml! , β-glucosidase was added and dissolved at a concentration of 200/d to make enzyme solution 1.
Seeds were prepared.
酵素溶液0.5J!f!に基質溶液(A)、(B)をそ
れぞれ別々に0.5dずつ加えて混合し、37°Cに放
置した。所定時間放置後10+Hの過ヨウ素酸カリウム
水溶液を添加し、610na+の吸光度を測定した。そ
の結果を第1表に示す。Enzyme solution 0.5J! f! 0.5 d of substrate solutions (A) and (B) were added to the solution and mixed, and the mixture was left at 37°C. After standing for a predetermined time, a 10+H potassium periodate aqueous solution was added, and the absorbance at 610na+ was measured. The results are shown in Table 1.
第1表
第1表から明らかな如く、フェノールインド−フェニル
α−ペンタオキサイドに対してα−グルコシダーゼとβ
−グルコシダーゼがわずかに作用して610nm吸光度
を1時間で0.360上昇させたのに対しイソプロピリ
デン−フェノールインド−フェニル−α−ペンタオサイ
ドはα−グルコシダーゼ等の作用を殆ど受けないので6
10nmの吸光度が0.010上昇したにすぎない。Table 1 As is clear from Table 1, α-glucosidase and β-glucosidase for phenolindo-phenyl α-pentaoxide
- Glucosidase acted slightly and the absorbance at 610 nm increased by 0.360 in 1 hour, whereas isopropylidene-phenolindo-phenyl-α-pentaoside is hardly affected by α-glucosidase etc.
The absorbance at 10 nm increased by only 0.010.
以上の結果から明らかな如(、一般式(Ilで示される
化合物はα−グルコシダーゼやθ−グルコシダーゼが殆
ど作用しないのでアミラーゼ測定試薬を一液化すること
が可能となり、測定操作上非常に有利であって、且つ測
定精度の向上に大きく寄与することができた。As is clear from the above results, since the compound represented by the general formula (Il) has almost no effect on α-glucosidase or θ-glucosidase, it is possible to use the reagent for measuring amylase in one solution, which is very advantageous in terms of measurement operation. In addition, we were able to make a significant contribution to improving measurement accuracy.
(4)α〜アミラーゼ活性の測定
前項(2ンで得られた化合物20m rmoρ、塩化カ
ルシウム10mmof及びα−グルコシダーゼ500単
位を精製水に溶かして、水酸化ナトリウムでpl+6.
9とし、全量を207とした。(4) Measurement of α-amylase activity (20 mmof of the compound obtained in step 2), 10 mmof of calcium chloride, and 500 units of α-glucosidase were dissolved in purified water, and added with sodium hydroxide to pl+6.
9, and the total amount was 207.
上記溶液2−に検体血清100pEを加え、37°Cに
加温した後、この反応液の波長610nmに於ける吸光
度変化を測定した。After adding 100 pE of sample serum to the above solution 2- and heating it to 37°C, the change in absorbance of this reaction solution at a wavelength of 610 nm was measured.
別に、α−アミラーゼ活性既知の標準検体を用い、上記
と同様に操作し、検量関係を求め、この検量線から検体
のα−アミラーゼ活性を求めた。Separately, using a standard specimen with known α-amylase activity, the same procedure as above was performed to determine the calibration relationship, and the α-amylase activity of the specimen was determined from this calibration curve.
このときの標準検体の各希釈段階に於けるα−アミラー
ゼ活性(Somogyi単位/dl)と波長610nm
に於ける1分間当りの吸光度増加N(ΔA)との関係を
第1図に示す。At this time, α-amylase activity (Somogyi units/dl) and wavelength of 610 nm at each dilution stage of the standard sample
FIG. 1 shows the relationship between the increase in absorbance N (ΔA) per minute and the increase in absorbance per minute.
第1図より明らかな如く、α−アミラーゼ活性(Soa
+ogyi単位/d)に対単位/口ットした吸光度増加
量(ΔA)を結ぶ検量線は原点を通る直線となり、検量
線は良好な定量性を示している。As is clear from Figure 1, α-amylase activity (Soa
The calibration curve connecting the increase in absorbance (ΔA) in pairs/units to +ogyi units/d) is a straight line passing through the origin, and the calibration curve shows good quantitative properties.
第1図から明らかなごとく、本発明の分析要素により管
理血清中のアミラーゼ活性を精度よく測定できた。As is clear from FIG. 1, amylase activity in control serum could be measured with high accuracy using the analytical element of the present invention.
本発明のインドフェニル配糖体の環状アセタール誘導体
は、α−アミラーゼにおいて基質として使用した場合に
血中の色素、例えばビリルビンやヘモグロビンによる妨
害や、予め含有しであるα又はβ−グルコシダーゼによ
る基質の分解を受けにく(、簡単な操作で、しかも検出
感度の高い測定をすることができる。When the cyclic acetal derivative of indophenyl glycoside of the present invention is used as a substrate in α-amylase, it is difficult to prevent interference by pigments in the blood, such as bilirubin and hemoglobin, and inhibition of the substrate by pre-contained α or β-glucosidase. Resistant to decomposition (can perform measurements with simple operation and high detection sensitivity).
第1図は、実施例で得られた検量線を示し、横軸の各α
−アミラーゼ活性(Somogyi単位/di)につい
て得られた吸光度増加量(ΔA)を横軸に沿ってプロッ
トした点を結んだものである。
特許出願人 富士写真フィルム株式会社代 理 人
弁理士 国中 政治 はか1名第1図Figure 1 shows the calibration curve obtained in the example, and each α on the horizontal axis
- The absorbance increase (ΔA) obtained for amylase activity (Somogyi units/di) is plotted along the horizontal axis and the points are connected. Patent applicant: Fuji Photo Film Co., Ltd. Agent
Patent attorney Kuninaka Politics 1 person Figure 1
Claims (1)
、ニトロ基、シアノ基、アジド基、アシル基−スルホン
酸基、ニトロソ基、スルホニル基、スルホキシル基、チ
オシアノ基、イソチオシアノ基、イソニトリル基、イミ
ノ基、アゾ基、ジアゾ基、アルキル基、アリル基又はア
リール基を意味し、X_3とX_4及び/又はX_5と
X_6は連結して縮合芳香環を形成してもよい。R_1
、R_2は同一又は異なって水素原子、低級アルキル基
またはフェニル基を意味し、R_1とR_2が共同して
シクロヘキサン環、シクロペンタン環を形成してもよい
、nは0から8までのいずれかの整数を表す。)で表わ
されるインドフェニル配糖体の環状アセタール誘導体2
、次式〔II〕 〔II〕 ▲数式、化学式、表等があります▼ (式中R_1、R_2、X_1及びX_2、nは請求項
1に記載のそれらと同義)で表わされる4−アミノフェ
ニル配糖体の環状アセタール誘導体に次式〔III〕▲数
式、化学式、表等があります▼〔III〕 (式中X_3ないしX_6は請求項1に記載のそれらと
同義)で表わされるキノン誘導体を作用させることを特
徴とする、請求項1に記載のインドフェニル配糖体の環
状アセタール誘導体の製法 3、アミラーゼの検出および定量的測定のための基質と
しての請求項1に記載のインドフェニル配糖体の環状ア
セタール誘導体の使用 4、検出および測定が補助酵素としてのα及び/又はβ
−グルコシダーゼの存在下に行われる請求項3に記載の
使用[Claims] 1. General formula [I] [I] ▲ Numerical formulas, chemical formulas, tables, etc.▼ (In the formula, X_1 to X_6 are hydrogen atoms, halogen atoms, nitro groups, cyano groups, azido groups, acyl Group - means a sulfonic acid group, nitroso group, sulfonyl group, sulfoxyl group, thiocyano group, isothiocyano group, isonitrile group, imino group, azo group, diazo group, alkyl group, allyl group or aryl group, X_3 and X_4 and/ Or X_5 and X_6 may be connected to form a condensed aromatic ring.R_1
, R_2 are the same or different and mean a hydrogen atom, a lower alkyl group, or a phenyl group, R_1 and R_2 may jointly form a cyclohexane ring or a cyclopentane ring, and n is any one from 0 to 8. Represents an integer. ) Cyclic acetal derivative of indophenyl glycoside 2
, the following formula [II] [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (wherein R_1, R_2, Cyclic acetal derivatives of saccharides include the following formula [III] ▲ Numerical formulas, chemical formulas, tables, etc. ▼ [III] (In the formula, X_3 to X_6 are the same as those described in claim 1). A method 3 for producing a cyclic acetal derivative of an indophenyl glycoside according to claim 1, characterized in that the indophenyl glycoside according to claim 1 is used as a substrate for detection and quantitative measurement of amylase Use of cyclic acetal derivatives 4, detection and measurement of α and/or β as auxiliary enzymes
- The use according to claim 3, which is carried out in the presence of glucosidase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12809089A JPH02306991A (en) | 1989-05-22 | 1989-05-22 | Cyclic acetal derivative of indophenyl-alpha-glycoside, its production and utilization thereof as reagent for measuring alpha-amylase activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12809089A JPH02306991A (en) | 1989-05-22 | 1989-05-22 | Cyclic acetal derivative of indophenyl-alpha-glycoside, its production and utilization thereof as reagent for measuring alpha-amylase activity |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02306991A true JPH02306991A (en) | 1990-12-20 |
Family
ID=14976157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12809089A Pending JPH02306991A (en) | 1989-05-22 | 1989-05-22 | Cyclic acetal derivative of indophenyl-alpha-glycoside, its production and utilization thereof as reagent for measuring alpha-amylase activity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02306991A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0768263B2 (en) * | 1991-04-23 | 1995-07-26 | ベーリンガー マンハイム ゲーエムベーハー | Indophenol-substituted maltooligosides as α-amylase substrates |
US5654163A (en) * | 1991-04-23 | 1997-08-05 | Boehringer Mannheim Gmbh | Indophenol substituted maltooligosides as α-amylase substrates |
-
1989
- 1989-05-22 JP JP12809089A patent/JPH02306991A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0768263B2 (en) * | 1991-04-23 | 1995-07-26 | ベーリンガー マンハイム ゲーエムベーハー | Indophenol-substituted maltooligosides as α-amylase substrates |
US5654163A (en) * | 1991-04-23 | 1997-08-05 | Boehringer Mannheim Gmbh | Indophenol substituted maltooligosides as α-amylase substrates |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0270946B1 (en) | Chromogenic acridinone enzyme substrates | |
US4697006A (en) | Modified oligosaccharides used as substrate for measuring α-amylase activity | |
Mollica et al. | Hydrolysis of benzothiadiazines | |
US4762917A (en) | Oligosaccharide derivatives and their use as substrate for measuring .alpha. | |
JPH02306991A (en) | Cyclic acetal derivative of indophenyl-alpha-glycoside, its production and utilization thereof as reagent for measuring alpha-amylase activity | |
JPH01157996A (en) | Maltooligo saccharide derivative and reagent for measuring amylase activity | |
JPH02306990A (en) | Indophenyl-alpha-glycoside, its production and utilization thereof as reagent for measuring alpha-amylase activity | |
JPS6087297A (en) | Cyclic acetal derivative of alpha,beta-nucleus-substituted phenylmaltooligoside, its preparation, and measurement of amylase activity using substrate thereof | |
EP0557021B1 (en) | Oligosaccharide derivatives suitable for alpha-amylase determination | |
JPH02178296A (en) | Novel glucosamine derivative, enzymatic activity determination reagent and process using the same | |
JP2770891B2 (en) | Maltooligoside derivative, reagent for measuring α-amylase activity using the same as active ingredient, and method for measuring α-amylase activity using the same | |
EP0459536A1 (en) | Chromogenic acridinone enzyme substrates | |
JPS63214193A (en) | Production of 6-glucosylmaltooligosaccharide derivative and measurement of alpha-amylase activity using said derivative | |
JPH04229196A (en) | Fractional determination of alpha-amylase isozyme activity | |
JPH0242096A (en) | Phenolindo-3'-azaphenyl-beta-d-glucoside derivative, production thereof and application thereof to reagent for measurement of beta-glucosidase activity | |
JP3029925B2 (en) | Maltooligosaccharide derivatives and their production | |
JP3124444B2 (en) | Method and reagent for measuring exo-type sugar hydrolase activity | |
JPH01256399A (en) | Measurement of alpha-amylase activity | |
JPH0358996A (en) | Indophenyl-beta-maltooligoside derivative, reagent for determining alpha-amylase activity and determination process for alpha-amylase activity using the same | |
JPS63129997A (en) | Substrate for determination of alpha-amylase activity and determination method | |
JPH03200801A (en) | Anhydromaltooligoside derivative, reagent for assaying alpha-amylase activity containing the same as effective component, and assay of alpha-amylase activity | |
JP3070709B2 (en) | Method for producing maltooligosaccharide derivatives | |
JP3266967B2 (en) | Novel oligosaccharide derivative, method for producing the same, and method for measuring α-amylase activity using the same as a substrate | |
JPS637797A (en) | Activity measurement of alpha-amylase | |
JPS63165401A (en) | 6-maltosylmaltooligosaccharide derivative, production thereof and measurement of alpha-amylase activity using said derivative |